146 related articles for article (PubMed ID: 33414085)
21. Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding.
Lin HJ
Aliment Pharmacol Ther; 2007 Feb; 25(3):343-4; author reply 344-5. PubMed ID: 17217451
[No Abstract] [Full Text] [Related]
22. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Keyvani L; Murthy S; Leeson S; Targownik LE
Aliment Pharmacol Ther; 2006 Oct; 24(8):1247-55. PubMed ID: 17014584
[TBL] [Abstract][Full Text] [Related]
23. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
Cook D; Guyatt G
N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497
[No Abstract] [Full Text] [Related]
24. Proton pump inhibitors for upper gastrointestinal bleeding.
Kherad O; Restellini S; Martel M; Barkun A
Best Pract Res Clin Gastroenterol; 2019; 42-43():101609. PubMed ID: 31785730
[TBL] [Abstract][Full Text] [Related]
25. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
Kawai T; Yagi K; Moriyasu F
Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
[TBL] [Abstract][Full Text] [Related]
26. Antisecretory therapy for bleeding peptic ulcer.
Peterson WL; Cook DJ
JAMA; 1998 Sep; 280(10):877-8. PubMed ID: 9739959
[No Abstract] [Full Text] [Related]
27. Prophylactic use of gastro-protective agents in patients on low-dose aspirin.
Balakrishnan S; Jhaj R
Br J Clin Pharmacol; 2008 Apr; 65(4):621-2. PubMed ID: 18294325
[No Abstract] [Full Text] [Related]
28. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
[TBL] [Abstract][Full Text] [Related]
29. [New data on the efficacy of proton pump inhibitors in upper gastrointestinal bleeding].
Calvet X
Gastroenterol Hepatol; 2010 May; 33 Suppl 1():11-4. PubMed ID: 20728784
[TBL] [Abstract][Full Text] [Related]
30. H2 Receptor Antagonists versus Proton Pump Inhibitors in Patients on Dual Antiplatelet Therapy for Coronary Artery Disease: A Systematic Review.
Almufleh A; Ramirez FD; So D; Le May M; Chong AY; Torabi N; Hibbert B
Cardiology; 2018; 140(2):115-123. PubMed ID: 29966126
[TBL] [Abstract][Full Text] [Related]
31. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
[TBL] [Abstract][Full Text] [Related]
32. Bleeding in the upper part of the gastrointestinal tract due to stress ulcers.
Carlson RW; Baker L; Andhavarapu S
Am J Crit Care; 2008 Mar; 17(2):148-9. PubMed ID: 18310652
[No Abstract] [Full Text] [Related]
33. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
[TBL] [Abstract][Full Text] [Related]
34. Clinically Significant Gastrointestinal Bleeding Using Proton Pump Inhibitors or Histamine Type-2 Receptor Antagonists in Patients Intubated for over 48 Hours: A Systematic Review and Meta-Analysis.
Khokher W; Kesireddy N; Iftikhar S; Beran A; Abuhelwa Z; Malhas SE; Saif T; Rashid R; Ali H; Malik A; Assaly R
Am J Ther; 2024 Jan-Feb 01; 31(1):e62-e66. PubMed ID: 35703440
[No Abstract] [Full Text] [Related]
35. Gastric Acid Suppression-More Data, Less Answers.
Tofil NM; Prabhakaran P
Pediatr Crit Care Med; 2015 Sep; 16(7):671-2. PubMed ID: 26335114
[No Abstract] [Full Text] [Related]
36. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding.
Enns RA; Gagnon YM; Rioux KP; Levy AR
Aliment Pharmacol Ther; 2003 Jan; 17(2):225-33. PubMed ID: 12534407
[TBL] [Abstract][Full Text] [Related]
37. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
38. Japan aims toward appropriate concomitant use of antiplatelets and antisecretory agents?
Fujishiro M
Intern Med; 2009; 48(21):1845-6. PubMed ID: 19881231
[No Abstract] [Full Text] [Related]
39. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
40. Effect of gastroprotective agents on upper gastrointestinal bleeding in patients receiving direct oral anticoagulants.
Youn SH; Lim H; Ju Y; Soh JS; Park JW; Kang HS; Kim SE; Moon SH; Kim JH; Park CK; Seo SI; Shin WG
Scand J Gastroenterol; 2018 Dec; 53(12):1490-1495. PubMed ID: 30509124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
